IP Library Assignment 041518/0749
Patent Assignment
Reel/Frame 041518/0749

Release of Security Interest

Recorded: 2017-03-09 Pages: 7
Assignors
CAPITAL ROYALTY PARTNERS II L.P.
Executed: 2017-03-03
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
5600 BLAZER PARKWAY, #200, DUBLIN, OHIO, 43017
Covered Properties (13)
Compositions, Methods and Kits for Diagnosing and Treating CD206 Expressing Cell-Related Disorders
Macromolecular carrier for drug and diagnostic agent delivery
Patent: 6,409,990 →
Application: 09/569,466 →
Novel Heteroaryl Substituted Benzoxazoles
Patent: 7,670,591 →
Application: 11/763,151 →
Publication: US 2008/0027051
Novel 2-Heteroaryl Substituted Benzothiophenes and Benzofuranes 709
Patent: 7,772,256 →
Application: 12/042,795 →
Publication: US 2008/0221149
Novel Heteroaryl Substituted Benzothiazoles
Patent: 8,163,928 →
Application: 12/162,255 →
Publication: US 2009/0028787
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Patent: 8,193,363 →
Application: 12/544,556 →
Publication: US 2010/0056796
Novel Heteroaryl Substituted Benzothiazoles
Patent: 8,957,215 →
Application: 13/453,579 →
Publication: US 2012/0207679
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Patent: 8,545,808 →
Application: 13/461,306 →
Publication: US 2012/0213700
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Patent: 8,653,274 →
Application: 13/487,349 →
Publication: US 2012/0264943
Compositions for Radiolabeling Diethylenetriaminepentaacetic Acid (Dtpa)-Dextran
Patent: 9,439,985 →
Application: 14/039,648 →
Publication: US 2014/0023586
Compounds Suitable as Precursors to Compounds That Are Useful for Imaging Amyloid Deposits
Patent: 9,309,267 →
Application: 14/149,563 →
Publication: US 2014/0296534
Compositions, Methods and Kits for Diagnosing and Treating CD206 Expressing Cell-Related Disorders
Application: 14/338,332 →
Publication: US 2015/0023876
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application: 62/106,194 →
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 12, 2000
From: VERA, DAVID R.
To: CALIFORNIA, UNIVERSITY OF THE REGENTS, THE
Reel/Frame 010805/0371 →
Assignment of Assignor's Interest Sep 12, 2007
From: MALMSTROM, JONAS; PYRING, DAVID; SLIVO, CAN; SOHN, DANIEL
To: ASTRAZENECA AB
Reel/Frame 019819/0898 →
Assignment of Assignor's Interest Mar 6, 2008
From: ARZEL, ERWAN; SWAHN, BRITT-MARIE; WENSBO, DAVID
To: ASTRAZENECA AB
Reel/Frame 020620/0192 →
Assignment of Assignor's Interest Jul 28, 2008
From: GRAVENFORS, YLVA; JONASSON, CATRIN; MALMSTROM, JONAS; PYRING, DAVID
To: ASTRAZENECA AB
Reel/Frame 021303/0422 →
Assignment of Assignor's Interest Oct 5, 2009
From: BJORK, SETH; JOHNSTROM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 023325/0674 →
Change of Name Aug 30, 2013
From: NEOPROBE CORPORATION
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 031125/0597 →
Assignment of Assignor's Interest Sep 27, 2013
From: ASTRAZENECA AB
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 031296/0347 →
Assignment of Assignor's Interest Jan 7, 2014
From: BJÖRK, SETH; JOHNSTRÖM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 031908/0476 →
Assignment of Assignor's Interest Jan 7, 2014
From: BJÖRK, SETH; JOHNSTRÖM, PETER; NILSSON, NILS ANDERS; RUDA, KATINKA
To: ASTRAZENECA AB
Reel/Frame 031909/0054 →
Security Interest May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Assignment of Assignor's Interest Sep 2, 2015
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 036477/0455 →
Release of Security Interest Dec 24, 2015
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 037357/0256 →
Change of Name Jan 13, 2016
From: NEOPROBE CORPORATION
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 037512/0596 →
Assignment of Assignor's Interest Jan 13, 2016
From: MAGNESON, GERALD R.; ORAHOOD, RICHARD C.
To: NEOPROBE CORPORATION
Reel/Frame 037481/0778 →
Assignment of Assignor's Interest May 9, 2016
From: SCHLESINGER, LARRY S.
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 038519/0221 →
Assignment of Assignor's Interest May 9, 2016
From: COPE, FREDERICK O.; BLUE, MICHAEL S.; METZ, WENDY L.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 038519/0060 →
Assignment of Assignor's Interest Mar 20, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 041645/0574 →
Assignment of Assignor's Interest Sep 1, 2020
From: THE OHIO STATE UNIVERSITY
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 053661/0639 →